Pharmacological treatment of neurogenic detrusor hyperactivity:: oral, patch, intravesical instillation

被引:4
作者
de Seze, M. [1 ]
Ruffion, A.
Chartier-Kastler, E.
机构
[1] Ctr Hosp Univ Bordeaux, Serv Reeduc Fonct, Bordeaux, France
[2] UCBL Lyon 1, Serv Urol Lyon Sud, Ctr Hosp Lyon Sud, Lyon, France
[3] Univ Paris 06, Serv Urol, GH Pitie Salpetriere, Paris, France
来源
PROGRES EN UROLOGIE | 2007年 / 17卷 / 03期
关键词
neurogenic bladder; overactive bladder; anticholinegic; vanilloid;
D O I
10.1016/S1166-7087(07)92368-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Functional rehabilitation of neurourological patients always starts with patient education, retraining, and occupational therapy, possibly completed by medical treatments. In the light of a systematic review of the literature, the authors describe the various treatments that can be used orally and by intravesical instillation in these patients. They also describe treatments such as desmopressin or agents that increase sphincter pressure, which can sometimes be very useful to obtain stable clinical results that are satisfactory for the patient.
引用
收藏
页码:559 / 563
页数:5
相关论文
共 58 条
[1]  
*AHPCPR, 1996, PUBL AHPCPR, V96
[2]  
Alberti Ingo, 2005, Expert Opin Drug Deliv, V2, P935, DOI 10.1517/17425247.2.5.935
[3]  
Amarenco G, 1995, REV NEUROL, V151, P722
[4]   New pharmacologic targets for the treatment of the overactive bladder: An update [J].
Andersson, KE .
UROLOGY, 2004, 63 (3A) :32-41
[5]  
Andersson KE, 1999, BJU INT, V84, P923
[6]  
ANDERSSON KE, 2000, 1 C INC PLYM PLYM DI, P479
[7]   Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin [J].
Apostolidis, A ;
Brady, CM ;
Yiangou, Y ;
Davis, J ;
Fowler, CJ ;
Anand, P .
UROLOGY, 2005, 65 (02) :400-405
[8]  
Appell RA, 2001, MAYO CLIN PROC, V76, P358
[9]  
BABU R, 1990, INT J CLIN PHARM TH, V28, P350
[10]   Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy [J].
Buyse, G ;
Verpoorten, C ;
Vereecken, R ;
Casaer, P .
EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 1995, 5 :31-34